Quezon City - The first Venous Endo – Intervention (VEIN)
Symposium was held last January 27, 2018, at the SEDA Vertis North Hotel in
Quezon City. It aims to become the
leading forum educating specific group of physicians interested in management
of patients with venous disorders. The
forum was very well – received by the Vascular community. A total of ninety – three (93) attendees
took part in the said symposium. The
participants were affiliated to over 40 hospitals all over the country and
practicing various sub – specialties. Of
the 93 participants, fifty – eight (58) were already consultants while thirty –
one (31) were trainees. They included
cardiologists, vascular internists, general, peripheral vascular, transplant,
cardio – thoracic surgeons and general practitioners.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7Y67Y8CEwRFbiOhpJLPSwIJNKOksJjyydt4U1Ij0vMXnTKW4AeHAq5tdcZGWt64cIxixHD6jazDc_WJzwjO4EhHpip98X5h9bnHgBhIVfvF1b1LG1u6ZZGCNg9yQOSWCa3-7vROkkNlQ/s1600/venous+1.jpg) |
Dr. E. T. Ona |
The symposium was opened by the Former Department of
Health Secretary, Dr. Enrique T. Ona
who was also the former president and founder of the Philippine Society for
Vascular Surgery. He delivered a very inspiring message that
recollected milestones in the Philippine vascular landscape, specifically in
the field of management of venous diseases.
In 1981, he founded of the Venous Forum of the Philippines. He recalled that the forum was created to
become a venue for a special group of physicians who were interested in the
treatment of venous disease. The Venous Forum was inclusive, that its members
were not limited to surgeons alone, but rather also involved internists,
cardiologists, and anyone who had interest in management in venous disorders. The Venous Forum was inclusive, that its
members were not limited to surgeons alone, but rather also involved
internists, cardiologists, and anyone who had interest in management in venous
disorders. In his speech, he sadly
expressed that the forum lost its luster over time, but with the rapid advances
and better understanding of the flow and venous physiology, instrumentation and
wound care, the resurgence of interest in said diseases had pushed
organizations, like PSVES to create an avenue of discussion about them. In the end, he also challenged the society to
become more proactive, relevant and significant in the management of other
vascular diseases like carotid arterial disease, aneurysm and peripheral
arterial diseases.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh95ZICLY-ToQouB-_atipsrSxStG31h6i4YF5sA7HV4nbuS_MpxGFaE36QYHflyLrmBPxYOIAq80VhNu0M5dNy2ci5BejcCEu0x8hdSxL5bBa6LX53UEL17dr9roGoy2w241RJE0uFC74/s1600/vein+2.jpg) |
Dr. Maria Rosa Abad and Dr. Ricardo Quintos II |
Dr. Maria Rosa C. Abad, one of the distinguished members
of the Department of Health - Health
Facilities and Services Regulatory Bureau, spoke about regulatory requirements
in setting – up ambulatory vein clinics.
She emphasized that there is an existing unit in the Department of
Health that is the Health Facilities and Services Regulatory Bureau. With safety and efficacy of health care
delivery, its functions encompass dissemination of regulatory policies and
standards for information and compliance of the ambulatory facility; issuance
of permits to construct, license to operate and certificate of accreditation;
monitoring of health facilities and services to ensure sustainability of health
facilities compliance with regulatory standards, among others.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjQYwl2NqPHyxY7FXKqf8LuEOYJiTnyCIHRnjMojw3HW4Eo4wLtG9Fes3XBxn3RKAh-QXkCgmVSvhIdICVDjf4ivlO8xe_KayFFKR0lzByaHM2ob78YmaHTG95yUSAmBLyPzyJvL54mmJU/s1600/vein+3.jpg) |
Dr. Joy M. Gali and Dr. Ricardo T. Quintos II |
Mastery of the use of ultrasound is another requirement
for anyone who wants to start vein practice or set – up an ambulatory vein
clinic. Dr. Joy M. Gali of the National
Kidney and Transplant Institute discussed the merits of personally doing the
diagnostic or venous imaging and accessing of vessels under ultrasound guidance
when doing the intervention. She gave a
concise lecture of the role of ultrasonography in venous disorders. She also stressed the existence of Philippine
Society of Ultrasound in Surgery (PSUS), the sole certifying society for use of
ultrasound in surgery. She mentioned the
requirements for being a fellow in the said society. The said organization is an affiliate of the
Philippine College of Surgeons.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgAyxROWOcBZwufcOEiv4Jhqg_TuuYIn57XSZ6Pvo_52O_WscqHPooN2MDdeHsOfJX8xC6PJawNFqbtH9N_PdFOF3doWsgjoZmESTCqLwDqgVOm-5XDtfHk3iTT5g8Y445F7BhgknoolWA/s1600/vein+4.jpg) |
Dr. Michael dela Cruz and Dr. Ricardo Quintos |
Dr. Michael
Anthony A. dela Cruz, a young Interventional Cardiologist from Cardinal
Santos Medical Center discussed principles of medical management of venous
insufficiency. He discussed venous
insufficiency as primary and secondary manifestation of venous hypertension
transmitted to the microcirculation. He
highlighted that pharmacotherapy in venous insufficiency is directed to
prevents inflammation and inhibits disease – related complication. He also stressed that these vasoactive
medications that increase the tone of the diseased vessels via the
nor-adrenalergic pathway thru vasoconstriction.
However, these medications are only adjunct to the use of compression
stockings, which is the mainstay in the management of venous insufficiency.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg-S2lA6yeLpS3GZ6dSKSzVnGumEQxjOhp9xNVUfov4oFWt8bG9AGnuym2jc4KSUsh1H44xwOIBcQZe0V1hs_oiLtNB0nNRC1aqA-OLSITYJ6jyzFFWfxzL1sxHtzYKjJrH3edbr-vCWto/s320/20180127-_MG_1625.jpg) |
Dr. Charlton S. Sibal |
Another Vascular surgeon, Dr. Charlton S. Sibal, from The
Lung Center of the Philippines, discussed the adjuvant therapies for venous
ulceration. He presented venous ulcer as
the end – point of venous insufficiency.
He discussed the its pathophysiology with emphasis on venous
hypertension and venous microangiography leads to eventual destruction of the
endothelial lining of the vein and then to venous ulceration. He presented different ways to management of
these venous ulcers, mentioning regimens of leg elevations, structured exercise
and compression therapy. He also showed
the role of hyperbaric therapy in patients with venous ulcers by presenting
cases their institution has managed using the said modality.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUmSiTZOn8K0_IXP72ZsLIy1hGrf2Puslpb5xEeh5BfTcbeK8Un8tEbAiwD9pmR93Xkm2BkUvHI1xa8AVX9ro-LnedDe3sOHGiRcc6nufjnncjxuPvEPy38VAt7cs9Pp7N48u2ScTZNKU/s320/20180127-_MG_1670.jpg) |
Dr. S. Simangan, D. V. Martires, Dr. R. Quintos II |
Dr. Vicente C. Martires, Jr, one of the most prominent
anesthesiologist from Cardinal Santos Medical Center, demonstrated the
different types of anesthesia given to patients undergoing surgical
intervention for venous diseases. He
displayed the benefits of subjecting patient to tumescent anesthesia,
emphasizing the role of hydro – dissection thru tumescence. This inexpensive mode of anesthesia delivery,
with corollary effect of decreased bleeding in minimally invasive venous
surgeries, decreased incidence of skin burns, avoidance of use of strong opiods
result to shorter recovery time for the patient.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjvE8rDIRAWGQdP_Rdq865d22FStrOlAXzwT0fNeePO4w-Wiew69OxuiAJUEFASubPSD6_J66TrAoPDAh3c7NYhIw66Qiah0OP5d90yLODPp9XtKHgodtqq4Dj2hV0vZlDBgMk_AQvYgIU/s320/20180127-_MG_1637.jpg) |
Dr. Leoncio L. Kaw |
From University of the Philippines – Philippine General
Hospital, Dr. Leoncio L. Kaw Jr. reviewed why open surgery remained to be the
gold standard in the care of patients with varicose veins. With the advent of improved endovenous technology,
he mentioned that the role of open surgery in venous diseases is increasingly
being questioned. He presented arguments
comparing open surgery techniques like high ligation, vein stripping, stab
phlebectomy to the modalities like radio frequency ablation, LASER therapy in
management of varicose veins. Recently
published papers still showed that open surgery maintains to its superiority in
management of varicose veins in terms of prevention of recurrence rate of
varicosities, patients’ satisfaction and costs. Accordingly, open surgery, particularly
vein stripping remains to be a durable and effective procedure in management of
varicose veins.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjUtstsCKhrm0O9BisbiL4Z0IdjMZ8xXG2vCHTaNkdhvqrYzE8M06PRgygVImIvx5ViV1x3A_54KroBvvLIi2rVzaphpsmpGduW0cBv_CqTw78QzCuqETXZTzDFySPt2XjmG4p-MegqpOE/s320/20180127-_MG_1743.jpg) |
Dr, Josefino I. Sanchez and Dr. Servando Simangan |
Several industry – sponsored lectures were
delivered. Dr. Josefino I. Sanchez from
the University of Sto. Tomas Hospital talked about post – endoveous LASER
treatment edema and the role of medications, particularly micronized purified
flavonoid fraction in its management .
The action of the said medication is lies in its ability to improve
venous tone and its ability to reduce the harmful effects induced by the
inflammatory mediators in venous hypertension of lower extremity veins during
venous insufficiency. These medications
are also known to improve the lymph flow and increase the number of lymphatics
and aids further absorption of excess fluid in the interstitium during
post—endovenous treatment – related edema.
However, these medications will work well, as a useful adjunct to
conventional therapy like compression stockings and surgery.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhpKeTixGd0XI2Sa8V3bjW4hVQsWFVIcDLAgnVIjXHtm1PSA_PPnhDRLoyVIjajVtxuvjP5aneji1ZSoEsOP4xSw2ciC_fgS56O8UN-DBkeXp1z-dV06W3Yv1Vlkm3ZeUwS5WQGnWQOMFk/s320/20180127-_MG_1759+%25282%2529.jpg) |
Dr. Quintos II, Dr. Chong Tze Tec & Dr. Simangan |
Another industry – sponsored lecture was on the pharmaco
– chemical ablation using endoluminal sealant (VenaSeal) by Dr. Chong Tze Tec
from Singapore General Hospital. This
new modality utilizes cyanoacrylate as the occlusive chemical that seals the
areas where it is endovenously injected into. Its property of being able to
quickly polymerize, it has the ability to maintain adhesion of the intimal
surfaces and prevents embolization to other areas. Accordingly, it is described
to be a modality that is that does not use tumescence, that does not utilize
heat and sclerosing agent to close the incompetent veins. Cases of patients with which the modality was
used were also presented. It was shown
that this new technique is comparable to radio frequency ablation, endovenous
LASER ablation.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhYe3k95EUU2llSPILnViJrxLtmuhMBywas7ASe8AzGkaxPm4dLkk3k74MZUWe0atbK0inOZfAZkbkG8jiAXwIf1Mko6Yx9_9KYtJPyo5fgcjVjvWYo1B5r9-Fxa-8HY7-2HKNGYsmFpQk/s320/20180127-_MG_1780.jpg) |
Dr. Quintos II, Dr. Tan Kia Lean and Dr. Simangan |
A lecture was delivered by Dr. Tan Kia Lean from Ara
Damansara Medical Center in
Malaysia. He talked about the
modality of percutaneous endoluminal endovenous mechanico – chemical ablation
of varicose veins. He described this
technique as novel technique which combined mechanical injury of the
endothelium with simultaneous infusion of physician – choice of liquid
sclerosant for the treatment of great saphenous vein and small saphenous vein
incompetence. It was also shown that
this new technique is safe, and an equivalent to other endovenous ablation
techniques.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgGi5TXsQguHZcuq5UcoX8EvL0MjyeLGZknJ2rvDXEXp4upk_wAUzOvDUhOCjO71pVm80NrPDI-rEPWg22mvFCwXvxepBl2bWgqLs3eBCPOLmluaDr-zDu_jKaZ7LhpLcuyWbMOhFynPjQ/s320/20180127-_MG_1801.jpg) |
Dr. Quintos II, Dr. Rainan Gloria and Dr. Simangan |
Dr. Rainan G. Gloria of the National Kidney and
Transplant Institute, on the other hand discussed the merits of radio –
frequency ablation therapy in incompetent superficial veins. He differentiated RFA from other endovenous
therapy for varicose veins by emphasizing that it uses radio – frequency
currents which heats up and destroys the venous endothelium at the site of
direct contact. This results to
shrinkage of collagen and endothelium denudation with later results to
obliteration of the venous lumen.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi7SIandwrm1YEB-Hv0W1JyKALIoobwaM9RSG_QCVAwuP7g8r5q0W1mPd6lNCV3bLH6-2o3Sw4avgrxTC6MO0zBCLVe3aqUdRgVyNUsBrU-4LU69lOkXoXopsVyznRmDlLaxFRM7m7cv18/s320/20180127-_MG_1793.jpg) |
Mr. Wendell Madriaga and Dr. Quintos II |
Mr. Wendell Madriaga of MEDEV Medical Devices Corporation
delivered a lecture on the role of endovenous LASER ablation (using Biolitech
EVLA) in venous insufficiency. He
explained that this modality delivers LASER energy with temperature over 100 C
close to the fiber tip of the catheter.
This will produce heat bubbles in the endothelial cells of the veins
that will eventually lead to its damage.
This again will result to contraction of the vessel with resultant
fibrosis of the vein. Delivery of energy
is adjusted according to the diameter of vessel involved and emphasis in the
intra – operative sizing of the veins was stressed.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEicv648RM2eYHejWGlL_BXtaFf31R_qEpX_KE5s0RO4CQRsDUpdqXRa-kKnhl_i6wxE2Q0PsFEpCID-i45pLOOVu_F8G_mvGsRu5XVTSNVizxbF6GISuHTy8k3N3X-3YElXFihXcF1xd-4/s320/20180127-_MG_1806.jpg) |
Dr. Quintos II, Dr. Jeffery Chua and Dr. Simangan |
Dr. Jeffery L. Chua of Makati Medical Center talked about
the ins and outs of sclerotherapy. He
displayed sclerotherapy as an endovenous chemical ablation by injection of
liquids and foamed sclerosing agent into intradermal, subcutaneous and
transfascial varicosed/incompetent veins.
He demonstrated the sclerosing agent causes damage of the endothelium of
the vein, resulting fibrosis of the said vein. He emphasized that
ultrasonography plays an important role in execution of the technique since
ultrasound aids in guiding the operator to selectively inject the sclerosant
into the vein, avoiding exsanguination of the agent out of the vein but into
the surrounding tissues.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhcXParYYdI4_B3xcVIklN2NfVsAVk8rMC-ilHXDGlnD8f1lI-iwKRmhuClhSfrQayuIS0pI8QiL8cPs_EeM6yTtBqonp7a-LObk7ERu_Xa7JjvERE8RaRrs0rYw4GCqcWvlb7-BdeFiQM/s320/20180127-_MG_1824.jpg) |
Dr. Ricardo Jose T. Quintos II |
Dr. Ricardo Jose DT. Quintos II of the Cardinal Santos
Medical Center delivered two very engaging lectures. The first one was the complications of
sclerotherapy and the second was basics of the non – contact LASER
therapy. In his first lecture, he
recognized that while the outcomes of sclerotherapy are numerous, it is not
free of complications, if not efficiently performed. These complications included
thrombophlebitis, anaphylaxis, deep vein thrombosis, cutaneous necrosis and
hyperpigmentation of the skin. Good
documentation of pre – procedural and post – procedural venous status was also
stressed. In his second lecture, he
discussed the physics of light amplification by simulated emission of radiation
(LASER) and its role in treatment of telangiectasia and spider veins. He emphasized that LASER treatment works on
the principle of selective photo - thermolysis where light is electively
absorbed by oxyhemoglobin of the leg veins, at suitable energies and pulse
durations and that cooling of the skin plays a very important role in
minimizing the thermal injuries to skin by the treatment itself.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgqMGn9hrIHu7Ow7djcr6zD7szg-tdmEwfeXXAE4TqPrZt94frcsydronoYiYmQIJ-4PWpmy0O5ahYWXalSZ_oBPz_d9vW9vtFI1i34-A_2ST0jalzcRCiIwLpuzHp1ESQiYyrXv1th4ME/s320/20180127-_MG_1845.jpg) |
Dr. L. Baloloy, Dr. Quintos II, Dr. Simangan |
The success of the first VEIN Symposium was also because
of the generous support from our 7 industry partners, namely Serveir, MEDEV,
Somotec, Corbridge, Medtronic, Getz Healthcare and RG Meditron.
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjAWjmdvG8-ZNUjkBdGS2io3IHXBW2aS9ZH7svIcTc-_kG934KU3pR8cT2xoyyee8hm60RANoDf4f8k8tbHpjhr9t7F5B9ju7dfFqHmBbej4falBSC5bzHgyK6CemipigskeO8mV3VdSFE/s640/20180127-_MG_1872.jpg) |
Delegates, VEIN Symposium 2018
|
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhI6RCKIoaj2TndiLfX8yAuaSvwoArVvhh5PYCCCfjOd02GkgW6J_b3X1cH5qNPnlcGKzQCkUUNbhFPN3RGbeO41vTJ4VVwjIj9iY8bZcY11Ugdbtt992etBBU8TAyrDeHquDD6AfE1t7o/s640/20180127-_MG_1858.jpg) |
Industry Partners with Dr. E. Ona, Dr. R. Quintos and Dr. S. Simangan, VEIN Symposium 2018 |
No comments:
Post a Comment